Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-25-052381
Filing Date
2025-05-23
Accepted
2025-05-23 15:27:47
Documents
72

Document Format Files

Seq Description Document Type Size
1 S-1 tm2415719-14_s1.htm S-1 5399242
2 EXHIBIT 3.1 tm2415719d15_ex3-1.htm EX-3.1 252538
3 EXHIBIT 3.2 tm2415719d15_ex3-2.htm EX-3.2 103279
4 EXHIBIT 3.3 tm2415719d15_ex3-3.htm EX-3.3 78147
5 EXHIBIT 3.4 tm2415719d15_ex3-4.htm EX-3.4 159750
6 EXHIBIT 4.2 tm2415719d15_ex4-2.htm EX-4.2 432392
7 EXHIBIT 10.1(A) tm2415719d15_ex10-1a.htm EX-10.1(A) 1519583
8 EXHIBIT 10.1(B) tm2415719d15_ex10-1b.htm EX-10.1(B) 81910
9 EXHIBIT 10.2(A) tm2415719d15_ex10-2a.htm EX-10.2(A) 213369
10 EXHIBIT 10.2(B) tm2415719d15_ex10-2b.htm EX-10.2(B) 81142
11 EXHIBIT 10.3(A) tm2415719d15_ex10-3a.htm EX-10.3(A) 499920
12 EXHIBIT 10.3(B) tm2415719d15_ex10-3b.htm EX-10.3(B) 413307
13 EXHIBIT 10.3(C) tm2415719d15_ex10-3c.htm EX-10.3(C) 521849
14 EXHIBIT 10.4(A) tm2415719d15_ex10-4a.htm EX-10.4(A) 183754
15 EXHIBIT 10.4(B) tm2415719d15_ex10-4b.htm EX-10.4(B) 76070
16 EXHIBIT 10.4(C) tm2415719d15_ex10-4c.htm EX-10.4(C) 73690
17 EXHIBIT 10.4(D) tm2415719d15_ex10-4d.htm EX-10.4(D) 78270
18 EXHIBIT 10.4(E) tm2415719d15_ex10-4e.htm EX-10.4(E) 64173
19 EXHIBIT 10.4(F) tm2415719d15_ex10-4f.htm EX-10.4(F) 69278
20 EXHIBIT 10.4(G) tm2415719d15_ex10-4g.htm EX-10.4(G) 69202
21 EXHIBIT 10.5 tm2415719d15_ex10-5.htm EX-10.5 155865
22 EXHIBIT 10.6 tm2415719d15_ex10-6.htm EX-10.6 105387
23 EXHIBIT 10.7 tm2415719d15_ex10-7.htm EX-10.7 74103
24 EXHIBIT 10.8 tm2415719d15_ex10-8.htm EX-10.8 16761
25 EXHIBIT 10.9 tm2415719d15_ex10-9.htm EX-10.9 85631
26 EXHIBIT 10.10 tm2415719d15_ex10-10.htm EX-10.10 19093
27 EXHIBIT 10.11 tm2415719d15_ex10-11.htm EX-10.11 12280
28 EXHIBIT 10.12 tm2415719d15_ex10-12.htm EX-10.12 98504
29 EXHIBIT 16.1 tm2415719d15_ex16-1.htm EX-16.1 2449
30 EXHIBIT 23.1 tm2415719d15_ex23-1.htm EX-23.1 1999
31 EXHIBIT 23.2 tm2415719d15_ex23-2.htm EX-23.2 1985
32 EXHIBIT 23.4 tm2415719d15_ex23-4.htm EX-23.4 16879
33 EX-FILING FEES tm2415719d15_ex-filingfees.htm EX-FILING FEES 21714
34 GRAPHIC bc_caris-4c.jpg GRAPHIC 97839
35 GRAPHIC bc_carispoanet-4c.jpg GRAPHIC 81557
36 GRAPHIC bc_casevolume-4c.jpg GRAPHIC 135027
37 GRAPHIC bc_novelcircul-4c.jpg GRAPHIC 104614
38 GRAPHIC bc_publications-4c.jpg GRAPHIC 190047
39 GRAPHIC fc_abcdaiassure-4c.jpg GRAPHIC 169224
40 GRAPHIC fc_centraldogma-4c.jpg GRAPHIC 65657
41 GRAPHIC fc_clinicalmole-4c.jpg GRAPHIC 220674
42 GRAPHIC fc_companion-4c.jpg GRAPHIC 120659
43 GRAPHIC fc_discovery-4c.jpg GRAPHIC 301384
44 GRAPHIC fc_keydevelop-4c.jpg GRAPHIC 93934
45 GRAPHIC fc_miprofile-4c.jpg GRAPHIC 263758
46 GRAPHIC fc_miprofile02-4c.jpg GRAPHIC 197502
47 GRAPHIC lc_colorectal-4c.jpg GRAPHIC 51461
48 GRAPHIC lc_oursolutions-4c.jpg GRAPHIC 108423
49 GRAPHIC lc_plasmabuffy-4c.jpg GRAPHIC 165820
50 GRAPHIC lc_significant-4c.jpg GRAPHIC 99531
51 GRAPHIC lg_carislifesciences-pn.jpg GRAPHIC 32014
52 GRAPHIC lg_datacliniclogo-4c.jpg GRAPHIC 267557
53 GRAPHIC pc_platform-4c.jpg GRAPHIC 163584
54 GRAPHIC pc_strategic-4c.jpg GRAPHIC 187809
55 GRAPHIC pc_unique-4c.jpg GRAPHIC 207999
56 GRAPHIC pc_unlocking-4c.jpg GRAPHIC 122347
57 GRAPHIC pg_bynumbers-4c.jpg GRAPHIC 344406
58 GRAPHIC pg_carislifesciences-4c.jpg GRAPHIC 517760
59 GRAPHIC pg_casevaluegrowth-4c.jpg GRAPHIC 142126
60 GRAPHIC pg_revenuegrowth-4c.jpg GRAPHIC 182132
61 GRAPHIC ph_cancercate-4c.jpg GRAPHIC 42981
62 GRAPHIC ph_powerofbigdata-4c.jpg GRAPHIC 57296
63 GRAPHIC tb_micancer-4c.jpg GRAPHIC 111254
64 GRAPHIC tb_micancerseek-4c.jpg GRAPHIC 98659
65 GRAPHIC tb_molecular-4c.jpg GRAPHIC 150107
66 GRAPHIC tb_panels-4c.jpg GRAPHIC 167453
67 GRAPHIC tb_technical-4c.jpg GRAPHIC 242325
68 GRAPHIC tm2415719d15_ex10-2aimg001.jpg GRAPHIC 1520
69 GRAPHIC tm2415719d15_ex10-2asp4img01.jpg GRAPHIC 2084
70 GRAPHIC tm2415719d15_ex10-3bsp2img2.jpg GRAPHIC 3389
71 GRAPHIC tm2415719d15_ex10-3bsp2img3.jpg GRAPHIC 7078
72 GRAPHIC tm2415719d15_ex10-3bsp4img1.jpg GRAPHIC 12812
  Complete submission text file 0001104659-25-052381.txt   18560616
Mailing Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039
Business Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039 (866) 771-8946
Caris Life Sciences, Inc. (Filer) CIK: 0002019410 (see all company filings)

EIN.: 852077369 | State of Incorp.: TX | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-287551 | Film No.: 25981732
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)